25 April 2013 - Deborah Wilkes
Archived
GlaxoSmithKline plans to divest its Lucozade and Ribena nutritional drinks brands, as the company seeks to focus its Consumer Healthcare division on fast-growing priority brands and emerging markets.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.